Metabolic HealthResearch PaperPaywall

Losing Weight Before Sleeve Gastrectomy Linked to Greater Weight Loss a Year After Surgery

In 436 sleeve gastrectomy patients, more weight lost before surgery tracked with more total weight loss at 1 year. Obesity drug use was tied to larger preop loss.

Wednesday, November 18, 2026 0 views
Published in Obesity (Silver Spring)
A bariatric surgeon in scrubs and cap operating laparoscopically with monitors showing the abdominal view in an operating room

Summary

Researchers at Yale reviewed records of 436 people who had sleeve gastrectomy, a weight-loss surgery, between 2020 and 2024. They grouped patients by how their weight changed before surgery: gained weight, lost 0-5%, lost 5-10%, or lost more than 10%. One year after surgery, total weight loss rose step by step across the groups, from about 22% in those who gained weight to about 32% in those who lost more than 10% beforehand. Roughly 41% of patients used obesity medications before surgery, including GLP-1 receptor agonists, and use was much more common in the group that lost the most (about 65%). Medication use was associated with more than three times the odds of losing over 10% before surgery. This was a retrospective, single-center study, so it shows associations, not cause and effect. It does not show that medications or preoperative weight loss directly produce better surgical results. This summary is based on the abstract only.

Detailed Summary

Obesity is a major driver of age-related disease, and bariatric surgery remains one of the most effective ways to reduce excess weight. Surgeons often ask patients to lose weight before the operation, and newer obesity drugs such as GLP-1 receptor agonists now make that more achievable. Whether preoperative loss, and the drugs behind it, change results after surgery is an open question.

Researchers at Yale School of Medicine ran a retrospective cohort study of 436 patients who underwent sleeve gastrectomy at one academic center from 2020 to 2024. Patients were sorted by weight change before surgery: weight gain (n=75), 0-5% loss (n=173), 5-10% loss (n=126), and more than 10% loss (n=62). The team compared percent total weight loss (%TWL) at 2 months, 6 months, and 1 year, and used logistic regression to find predictors of losing more than 10% before surgery.

Results showed a graded pattern. At 1 year, %TWL was 22.3% in the weight-gain group, 25.9% with 0-5% loss, 27.1% with 5-10% loss, and 31.7% with more than 10% loss (p<0.0001). Differences were significant at every time point. Overall, 41.5% of patients used obesity medications before surgery, ranging from 22.7% in the weight-gain group to 64.5% in the greatest-loss group. Medication use was associated with more than 10% preoperative loss (OR 3.3, 95% CI 1.8-6.1).

The findings suggest that patients who lose more weight before surgery tend to lose more afterward, and that obesity medications may help patients get there. This is a surface-level link, though, not a demonstrated mechanism or a measure of lifespan or health outcomes.

Caveats matter. The design is retrospective and from a single center, so confounding is likely: motivated, healthier, or better-resourced patients may both lose more beforehand and do better afterward. The abstract does not report drug-specific effects, dosing, or complications. Because only the abstract was available, details are limited.

Key Findings

  • At 1 year, %TWL rose stepwise: 22.3% (weight gain), 25.9% (0-5% loss), 27.1% (5-10%), 31.7% (>10% loss); p<0.0001.
  • Retrospective cohort of 436 sleeve gastrectomy patients at one academic center, 2020-2024.
  • 41.5% used obesity medications before surgery, from 22.7% in the weight-gain group to 64.5% in the >10% loss group.
  • Medication use was associated with >10% preoperative loss (OR 3.3, 95% CI 1.8-6.1); this is association, not causation.
  • Differences in %TWL were significant at 2 months, 6 months, and 1 year; no complication or lifespan data are reported in the abstract.

Methodology

Retrospective single-center cohort of 436 sleeve gastrectomy patients (2020-2024), grouped by preoperative weight change. Outcomes were %TWL at 2 months, 6 months, and 1 year, with logistic regression for predictors of >10% preoperative loss. Evidence level is observational, with a weight-based surrogate endpoint.

Study Limitations

This summary is based on the abstract only. The retrospective, single-center design leaves residual confounding (patient motivation, baseline characteristics, access to medications), and the abstract gives no drug-specific, dosing, complication, or long-term data beyond 1 year. Follow-up is short and causal conclusions are not possible.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: